Pierre Fabre (Germany)

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 10 of 152 papers

  • Open Access
  • PDF
  • Research Article
  • Citations1

La basílica-sinagoga de l'Alcúdia d'Elx (1905-2005). Problemes i estat de la qüestió 100 anys després

  • Nov 27, 2025
  • Lucentum
  • Roberto Lorenzo De San Román
  • Research Article

P2.06.43 Estimating Tumour Microenvironment Cellular States From Bulk RNAseq Produces Biomarkers of Clinical Outcome Across Stages

  • Oct 01, 2025
  • Journal of Thoracic Oncology
  • Mónica A Hurtado +32
  • Open Access
  • Research Article

On the nature and causes of poverty: an analysis of some aspects of Adam Smith’s social philosophy

  • Jul 31, 2024
  • Revista Economia Ensaios
  • Fernando Sérgio De Toledo Fonseca +1
  • Open Access
  • Preprint Article

A novel methodological framework for the analysis of health trajectories and survival outcomes in heart failure patients

  • Mar 05, 2024
  • arXiv (Cornell University)
  • Juliette Murris +5
  • Research Article

Après-coup

  • Jan 01, 2024
  • Perspectives Psy
  • Jean-François Lebrun +2
  • Research Article

Mélancolie des théories sexuelles infantiles

  • Nov 02, 2023
  • Revue française de psychanalyse
  • Emmanuelle Sabouret
  • Open Access
  • Research Article

Rezension von: Bumiller, Casimir; Rüth, Bernhard; Weber, Ewin Ernst (Hrsg.), Mäzene, Sammler, Chronisten

  • Jul 17, 2023
  • Ulm und Oberschwaben
  • Manfred Waßner +3
  • Open Access
  • PDF
  • Preprint Article
  • Citations7

A Sample-Centric and Knowledge-Driven Computational Framework for Natural Products Drug Discovery

  • Jul 02, 2023
  • ChemRxiv
  • Arnaud Gaudry +13
  • Research Article

Le pilotage coordonné des consommations pour mener à bien la transition énergétique

  • Mar 14, 2023
  • Annales des Mines - Responsabilité et environnement
  • Pierre Bivas
  • Open Access
  • Abstract

P014 Interim analysis of ELEANOR (n = 200): a multi-national, prospective, non-interventional study (NIS) among patients with HER2+ and HR+ early breast cancer (eBC) treated with extended adjuvant neratinib

  • Mar 14, 2023
  • The Breast
  • R Bartsch +19
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.